货号:GS40362
Landogrozumab is a humanized monoclonal antibody designed to target and neutralize myostatin (GDF8), a negative regulator of skeletal muscle growth. By binding to myostatin, it blocks its interaction with the activin type II receptor (ActRIIB), thereby aiming to promote muscle hypertrophy and prevent muscle loss. It has been investigated in clinical trials for conditions involving muscle atrophy and wasting, such as sarcopenia in older adults and cachexia associated with cancer.
武汉迈思生物科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
迈思生物